Eric Bjerkholt

Insider Reports History

Location
Kengsington, CA
Signature
/s/ Charles Williams, Attorney-in-Fact for Eric Bjerkholt
Transaction view
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Eric Bjerkholt:

Form 4 holding Director

CERUS CORP

Security class
Common Stock
Shares / value
222,133
Estimated value
$290,994
Report date
03 Jun 2025
Price
$1.31
Ownership
Direct
Form 4 holding CHIEF FINANCIAL OFFICER

Mirum Pharmaceuticals, Inc.

Security class
Restricted Stock Units
Shares / value
11,760
Estimated value
$255,581
Report date
28 Jan 2026
Price
$47.92
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CHIEF FINANCIAL OFFICER

Mirum Pharmaceuticals, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
29,046
Estimated value
Report date
12 Aug 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CalciMedica, Inc.

Security class
Director Stock Option (Right to Buy)
Shares / value
10,000
Estimated value
Report date
27 Aug 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Metagenomi, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
8,572
Estimated value
Report date
10 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CHIEF FINANCIAL OFFICER

Mirum Pharmaceuticals, Inc.

Security class
Performance Restricted Stock Units
Shares / value
6,666
Estimated value
Report date
15 Mar 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Surrozen, Inc./DE

Security class
Director Stock Option (right to buy)
Shares / value
5,550
Estimated value
Report date
13 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Surrozen, Inc./DE

Security class
Option (right to buy)
Shares / value
1,333
Estimated value
Report date
14 May 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Surrozen, Inc./DE

Security class
Option (right to buy)
Shares / value
1,333
Estimated value
Report date
05 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

CHINOOK THERAPEUTICS, INC.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
Report date
11 Aug 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

CHINOOK THERAPEUTICS, INC.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
11 Aug 2023
Price
$26.12
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Eric Bjerkholt

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .